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MMP-12 hydrolyzes collagens and elastin in normal physiological processes of development, wound repair, and 
reconstruction of the extracellular matrix. However, chronically elevated levels of MMP-12 activity can sustain disease 
states in certain tissues. Excessive MMP-12 activity upon elastic fibrils of lungs and arteries causes inflammation at 
those sites, resulting in emphysema, while excessive activity upon collagens triggers rupture of atheromatous 
plaques, which can lead to heart attack or stroke. Thus, research into the binding site interactions between MMP-12 
and macromolecular substrates provides surface characterization of the enzyme and expedites the process of 
designing artificial inhibitor molecules to selectively inactivate MMP-12. The catalytic domain of MMP-12 spans amino 
acid residue 100 to 263, and this region is particularly important during hydrolysis of substrates. Three secondary 
binding sites within the catalytic domain were examined: phenylalanine 202 (F202), threonine 205 (T205), and 
histidine 206 (H206). Site-directed mutagenesis was performed at the aforementioned exosites to obtain single point 
mutations glutamine 202 (F202Q), lysine 205 (T205K), and histidine 206 (H206D). The MMP-12 mutants were 
expressed as the 18.2kDa catalytic domain in BL21 derived E. coli Rosetta™ 2 host strains. The mutated MMP-12 
enzymes were isolated as insoluble inclusion bodies after lysis of E. coli cells using the French press. The inclusion 
bodies were solubilized in neutral 6M urea buffer, and preliminary purification with cation-exchange chromatography 
yielded a nucleic acid-free fraction of denatured enzyme. Refolding of the MMP-12 mutants was done by dialysis with 
serially diluted urea solution containing Tris-HCl buffer and CaCl2 at pH 7.5 without Zn++. ZnCl2 was added to the 
final dialysis buffer to complete the refolding process.  Final purification of active renatured enzyme was achieved by 
another cation exchange chromatography run. Then, a Bio-Rad protein assay determined the concentration of the 
three MMP-12 mutants. Two types of flurometric-based kinetic experiments were performed to study changes in 
catalytic activity of the three MMP-12 mutants versus wild-type MMP-12: active site titration and substrate activity. 
Active site titration quantified the concentration of active sites for each MMP-12 mutant. The substrate runs for the 
substrates FS-6, fluorescently labeled elastin, and a triple helical peptide mimic of collagen V (THP-V) produced raw 
kinetics data, in the form of progress curves. Microcal Origin Pro 7.5 was used to analyze the data to give the kcat, 
the number of times each enzyme site converts substrate to product per second, and the Km, the concentration 
needed to achieve one half Vmax. Furthermore, dividing Kcat by Km revealed the amount of activity upon FS-6, elastin, 
and THP-V for each MMP-12 mutant with FS-6 as the control for mutated and wild-type MMP-12. Since the kcat/Km for 
wild-type MMP-12 was already known, comparison of activity upon THP-V and elastin between wild type MMP-12 
and each MMP-12 mutant was achieved. Ongoing data collection suggests diminished catalytic activity upon elastin 
and THP-V in all three MMP-12 mutants (F202Q, T205K, and H206D) when compared to wild-type MMP-12, while 
showing no decrease in activity upon the general MMP substrate, FS-6. To date, data suggests that all three exosites 
are individually involved in fine-tuning MMP-12 specificity for elastin and triple helical peptide mimics of collagen V. 
